Vaccine Contract Manufacturing Market
Vaccine Contract Manufacturing Market - Global Industry Assessment & Forecast
#
Pages:
142
Base Year:
2022
Sep - 2023
Format:
Report Code:
VMR-2269
Segments Covered
By
Vaccine Type Live Attenuated Vaccines , Conjugate Vaccines, Subunit Subunit Vaccines, Inactivated Vaccines, Recombinant Vector Vaccines, Toxoid Vaccines, Synthetic Vaccines
-
By
Service Type Fill-Finish, Bulk Product
-
By
Product Type Single Vaccine, Combination Vaccine
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 3.1 Billion |
 Revenue 2030:
|
USD 7.4 Billion |
 Revenue CAGR
(2023 - 2030): |
11.5% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Vaccine Contract Manufacturing Market Segment Analysis
- Vaccine Contract Manufacturing Vaccine Type Outlook (Revenue, USD Million, 2018 - 2030)
- Live Attenuated Vaccines
- Conjugate Vaccines
- Subunit Subunit Vaccines
- Inactivated Vaccines
- Recombinant Vector Vaccines
- Toxoid Vaccines
- Synthetic Vaccines
- Vaccine Contract Manufacturing Service Type Outlook (Revenue, USD Million, 2018 - 2030)
- Fill-Finish
- Bulk Product
- Vaccine Contract Manufacturing Product Type Outlook (Revenue, USD Million, 2018 - 2030)
- Single Vaccine
- Combination Vaccine
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Vaccine Contract Manufacturing Market, by Vaccine Type
- Live Attenuated Vaccines
- Conjugate Vaccines
- Subunit Subunit Vaccines
- Inactivated Vaccines
- Recombinant Vector Vaccines
- Toxoid Vaccines
- Synthetic Vaccines
-
North America Vaccine Contract Manufacturing Market, by Service Type
- Fill-Finish
- Bulk Product
-
North America Vaccine Contract Manufacturing Market, by Product Type
- Single Vaccine
- Combination Vaccine
- U.S.
- U.S. Vaccine Contract Manufacturing Market, by Vaccine Type
- Live Attenuated Vaccines
- Conjugate Vaccines
- Subunit Subunit Vaccines
- Inactivated Vaccines
- Recombinant Vector Vaccines
- Toxoid Vaccines
- Synthetic Vaccines
- U.S. Vaccine Contract Manufacturing Market, by Service Type
- Fill-Finish
- Bulk Product
- U.S. Vaccine Contract Manufacturing Market, by Product Type
- Single Vaccine
- Combination Vaccine
- U.S. Vaccine Contract Manufacturing Market, by Vaccine Type
- Canada
- Canada Vaccine Contract Manufacturing Market, by Vaccine Type
- Live Attenuated Vaccines
- Conjugate Vaccines
- Subunit Subunit Vaccines
- Inactivated Vaccines
- Recombinant Vector Vaccines
- Toxoid Vaccines
- Synthetic Vaccines
- Canada Vaccine Contract Manufacturing Market, by Service Type
- Fill-Finish
- Bulk Product
- Canada Vaccine Contract Manufacturing Market, by Product Type
- Single Vaccine
- Combination Vaccine
- Canada Vaccine Contract Manufacturing Market, by Vaccine Type
-
Mexico
- Mexico Vaccine Contract Manufacturing Market, by Vaccine Type
- Live Attenuated Vaccines
- Conjugate Vaccines
- Subunit Subunit Vaccines
- Inactivated Vaccines
- Recombinant Vector Vaccines
- Toxoid Vaccines
- Synthetic Vaccines
- Mexico Vaccine Contract Manufacturing Market, by Service Type
- Fill-Finish
- Bulk Product
- Mexico Vaccine Contract Manufacturing Market, by Product Type
- Single Vaccine
- Combination Vaccine
- Mexico Vaccine Contract Manufacturing Market, by Vaccine Type
-
North America Vaccine Contract Manufacturing Market, by Vaccine Type
- Europe
-
Europe Vaccine Contract Manufacturing Market, by Vaccine Type
- Live Attenuated Vaccines
- Conjugate Vaccines
- Subunit Subunit Vaccines
- Inactivated Vaccines
- Recombinant Vector Vaccines
- Toxoid Vaccines
- Synthetic Vaccines
-
Europe Vaccine Contract Manufacturing Market, by Service Type
- Fill-Finish
- Bulk Product
-
Europe Vaccine Contract Manufacturing Market, by Product Type
- Single Vaccine
- Combination Vaccine
- U. K.
- U.K. Vaccine Contract Manufacturing Market, by Vaccine Type
- Live Attenuated Vaccines
- Conjugate Vaccines
- Subunit Subunit Vaccines
- Inactivated Vaccines
- Recombinant Vector Vaccines
- Toxoid Vaccines
- Synthetic Vaccines
- U.K. Vaccine Contract Manufacturing Market, by Service Type
- Fill-Finish
- Bulk Product
- U.K. Vaccine Contract Manufacturing Market, by Product Type
- Single Vaccine
- Combination Vaccine
- U.K. Vaccine Contract Manufacturing Market, by Vaccine Type
- France
- France Vaccine Contract Manufacturing Market, by Vaccine Type
- Live Attenuated Vaccines
- Conjugate Vaccines
- Subunit Subunit Vaccines
- Inactivated Vaccines
- Recombinant Vector Vaccines
- Toxoid Vaccines
- Synthetic Vaccines
- France Vaccine Contract Manufacturing Market, by Service Type
- Fill-Finish
- Bulk Product
- France Vaccine Contract Manufacturing Market, by Product Type
- Single Vaccine
- Combination Vaccine
- France Vaccine Contract Manufacturing Market, by Vaccine Type
-
Germany
- Germany Vaccine Contract Manufacturing Market, by Vaccine Type
- Live Attenuated Vaccines
- Conjugate Vaccines
- Subunit Subunit Vaccines
- Inactivated Vaccines
- Recombinant Vector Vaccines
- Toxoid Vaccines
- Synthetic Vaccines
- Germany Vaccine Contract Manufacturing Market, by Service Type
- Fill-Finish
- Bulk Product
- Germany Vaccine Contract Manufacturing Market, by Product Type
- Single Vaccine
- Combination Vaccine
- Germany Vaccine Contract Manufacturing Market, by Vaccine Type
-
Italy
- Italy Vaccine Contract Manufacturing Market, by Vaccine Type
- Live Attenuated Vaccines
- Conjugate Vaccines
- Subunit Subunit Vaccines
- Inactivated Vaccines
- Recombinant Vector Vaccines
- Toxoid Vaccines
- Synthetic Vaccines
- Italy Vaccine Contract Manufacturing Market, by Service Type
- Fill-Finish
- Bulk Product
- Italy Vaccine Contract Manufacturing Market, by Product Type
- Single Vaccine
- Combination Vaccine
- Italy Vaccine Contract Manufacturing Market, by Vaccine Type
-
Spain
- Spain Vaccine Contract Manufacturing Market, by Vaccine Type
- Live Attenuated Vaccines
- Conjugate Vaccines
- Subunit Subunit Vaccines
- Inactivated Vaccines
- Recombinant Vector Vaccines
- Toxoid Vaccines
- Synthetic Vaccines
- Spain Vaccine Contract Manufacturing Market, by Service Type
- Fill-Finish
- Bulk Product
- Spain Vaccine Contract Manufacturing Market, by Product Type
- Single Vaccine
- Combination Vaccine
- Spain Vaccine Contract Manufacturing Market, by Vaccine Type
-
Rest of Europe
- Rest of Europe Vaccine Contract Manufacturing Market, by Vaccine Type
- Live Attenuated Vaccines
- Conjugate Vaccines
- Subunit Subunit Vaccines
- Inactivated Vaccines
- Recombinant Vector Vaccines
- Toxoid Vaccines
- Synthetic Vaccines
- Rest of Europe Vaccine Contract Manufacturing Market, by Service Type
- Fill-Finish
- Bulk Product
- Rest of Europe Vaccine Contract Manufacturing Market, by Product Type
- Single Vaccine
- Combination Vaccine
- Rest of Europe Vaccine Contract Manufacturing Market, by Vaccine Type
-
Europe Vaccine Contract Manufacturing Market, by Vaccine Type
- Asia Pacific
-
Asia Pacific Vaccine Contract Manufacturing Market, by Vaccine Type
- Live Attenuated Vaccines
- Conjugate Vaccines
- Subunit Subunit Vaccines
- Inactivated Vaccines
- Recombinant Vector Vaccines
- Toxoid Vaccines
- Synthetic Vaccines
-
Asia Pacific Vaccine Contract Manufacturing Market, by Service Type
- Fill-Finish
- Bulk Product
-
Asia Pacific Vaccine Contract Manufacturing Market, by Product Type
- Single Vaccine
- Combination Vaccine
- China
- China Vaccine Contract Manufacturing Market, by Vaccine Type
- Live Attenuated Vaccines
- Conjugate Vaccines
- Subunit Subunit Vaccines
- Inactivated Vaccines
- Recombinant Vector Vaccines
- Toxoid Vaccines
- Synthetic Vaccines
- China Vaccine Contract Manufacturing Market, by Service Type
- Fill-Finish
- Bulk Product
- China Vaccine Contract Manufacturing Market, by Product Type
- Single Vaccine
- Combination Vaccine
- China Vaccine Contract Manufacturing Market, by Vaccine Type
- Japan
- Japan Vaccine Contract Manufacturing Market, by Vaccine Type
- Live Attenuated Vaccines
- Conjugate Vaccines
- Subunit Subunit Vaccines
- Inactivated Vaccines
- Recombinant Vector Vaccines
- Toxoid Vaccines
- Synthetic Vaccines
- Japan Vaccine Contract Manufacturing Market, by Service Type
- Fill-Finish
- Bulk Product
- Japan Vaccine Contract Manufacturing Market, by Product Type
- Single Vaccine
- Combination Vaccine
- Japan Vaccine Contract Manufacturing Market, by Vaccine Type
-
Germany
- Germany Vaccine Contract Manufacturing Market, by Vaccine Type
- Live Attenuated Vaccines
- Conjugate Vaccines
- Subunit Subunit Vaccines
- Inactivated Vaccines
- Recombinant Vector Vaccines
- Toxoid Vaccines
- Synthetic Vaccines
- Germany Vaccine Contract Manufacturing Market, by Service Type
- Fill-Finish
- Bulk Product
- Germany Vaccine Contract Manufacturing Market, by Product Type
- Single Vaccine
- Combination Vaccine
- Germany Vaccine Contract Manufacturing Market, by Vaccine Type
-
India
- India Vaccine Contract Manufacturing Market, by Vaccine Type
- Live Attenuated Vaccines
- Conjugate Vaccines
- Subunit Subunit Vaccines
- Inactivated Vaccines
- Recombinant Vector Vaccines
- Toxoid Vaccines
- Synthetic Vaccines
- India Vaccine Contract Manufacturing Market, by Service Type
- Fill-Finish
- Bulk Product
- India Vaccine Contract Manufacturing Market, by Product Type
- Single Vaccine
- Combination Vaccine
- India Vaccine Contract Manufacturing Market, by Vaccine Type
-
South Korea
- South Korea Vaccine Contract Manufacturing Market, by Vaccine Type
- Live Attenuated Vaccines
- Conjugate Vaccines
- Subunit Subunit Vaccines
- Inactivated Vaccines
- Recombinant Vector Vaccines
- Toxoid Vaccines
- Synthetic Vaccines
- South Korea Vaccine Contract Manufacturing Market, by Service Type
- Fill-Finish
- Bulk Product
- South Korea Vaccine Contract Manufacturing Market, by Product Type
- Single Vaccine
- Combination Vaccine
- South Korea Vaccine Contract Manufacturing Market, by Vaccine Type
-
South East Asia
- South East Asia Vaccine Contract Manufacturing Market, by Vaccine Type
- Live Attenuated Vaccines
- Conjugate Vaccines
- Subunit Subunit Vaccines
- Inactivated Vaccines
- Recombinant Vector Vaccines
- Toxoid Vaccines
- Synthetic Vaccines
- South East Asia Vaccine Contract Manufacturing Market, by Service Type
- Fill-Finish
- Bulk Product
- South East Asia Vaccine Contract Manufacturing Market, by Product Type
- Single Vaccine
- Combination Vaccine
- South East Asia Vaccine Contract Manufacturing Market, by Vaccine Type
-
Rest of Asia Pacific
- Rest of Asia Pacific Vaccine Contract Manufacturing Market, by Vaccine Type
- Live Attenuated Vaccines
- Conjugate Vaccines
- Subunit Subunit Vaccines
- Inactivated Vaccines
- Recombinant Vector Vaccines
- Toxoid Vaccines
- Synthetic Vaccines
- Rest of Asia Pacific Vaccine Contract Manufacturing Market, by Service Type
- Fill-Finish
- Bulk Product
- Rest of Asia Pacific Vaccine Contract Manufacturing Market, by Product Type
- Single Vaccine
- Combination Vaccine
- Rest of Asia Pacific Vaccine Contract Manufacturing Market, by Vaccine Type
-
Asia Pacific Vaccine Contract Manufacturing Market, by Vaccine Type
- Latin America
-
Latin America Vaccine Contract Manufacturing Market, by Vaccine Type
- Live Attenuated Vaccines
- Conjugate Vaccines
- Subunit Subunit Vaccines
- Inactivated Vaccines
- Recombinant Vector Vaccines
- Toxoid Vaccines
- Synthetic Vaccines
-
Latin America Vaccine Contract Manufacturing Market, by Service Type
- Fill-Finish
- Bulk Product
-
Latin America Vaccine Contract Manufacturing Market, by Product Type
- Single Vaccine
- Combination Vaccine
- Brazil
- Brazil Vaccine Contract Manufacturing Market, by Vaccine Type
- Live Attenuated Vaccines
- Conjugate Vaccines
- Subunit Subunit Vaccines
- Inactivated Vaccines
- Recombinant Vector Vaccines
- Toxoid Vaccines
- Synthetic Vaccines
- Brazil Vaccine Contract Manufacturing Market, by Service Type
- Fill-Finish
- Bulk Product
- Brazil Vaccine Contract Manufacturing Market, by Product Type
- Single Vaccine
- Combination Vaccine
- Brazil Vaccine Contract Manufacturing Market, by Vaccine Type
- Argentina
- Argentina Vaccine Contract Manufacturing Market, by Vaccine Type
- Live Attenuated Vaccines
- Conjugate Vaccines
- Subunit Subunit Vaccines
- Inactivated Vaccines
- Recombinant Vector Vaccines
- Toxoid Vaccines
- Synthetic Vaccines
- Argentina Vaccine Contract Manufacturing Market, by Service Type
- Fill-Finish
- Bulk Product
- Argentina Vaccine Contract Manufacturing Market, by Product Type
- Single Vaccine
- Combination Vaccine
- Argentina Vaccine Contract Manufacturing Market, by Vaccine Type
-
Rest of Latin America
- Rest of Latin America Vaccine Contract Manufacturing Market, by Vaccine Type
- Live Attenuated Vaccines
- Conjugate Vaccines
- Subunit Subunit Vaccines
- Inactivated Vaccines
- Recombinant Vector Vaccines
- Toxoid Vaccines
- Synthetic Vaccines
- Rest of Latin America Vaccine Contract Manufacturing Market, by Service Type
- Fill-Finish
- Bulk Product
- Rest of Latin America Vaccine Contract Manufacturing Market, by Product Type
- Single Vaccine
- Combination Vaccine
- Rest of Latin America Vaccine Contract Manufacturing Market, by Vaccine Type
-
Latin America Vaccine Contract Manufacturing Market, by Vaccine Type
- Middle East & Africa
-
Middle East & Africa Vaccine Contract Manufacturing Market, by Vaccine Type
- Live Attenuated Vaccines
- Conjugate Vaccines
- Subunit Subunit Vaccines
- Inactivated Vaccines
- Recombinant Vector Vaccines
- Toxoid Vaccines
- Synthetic Vaccines
-
Middle East & Africa Vaccine Contract Manufacturing Market, by Service Type
- Fill-Finish
- Bulk Product
-
Middle East & Africa Vaccine Contract Manufacturing Market, by Product Type
- Single Vaccine
- Combination Vaccine
- GCC Countries
- GCC Countries Vaccine Contract Manufacturing Market, by Vaccine Type
- Live Attenuated Vaccines
- Conjugate Vaccines
- Subunit Subunit Vaccines
- Inactivated Vaccines
- Recombinant Vector Vaccines
- Toxoid Vaccines
- Synthetic Vaccines
- GCC Countries Vaccine Contract Manufacturing Market, by Service Type
- Fill-Finish
- Bulk Product
- GCC Countries Vaccine Contract Manufacturing Market, by Product Type
- Single Vaccine
- Combination Vaccine
- GCC Countries Vaccine Contract Manufacturing Market, by Vaccine Type
- South Africa
- South Africa Vaccine Contract Manufacturing Market, by Vaccine Type
- Live Attenuated Vaccines
- Conjugate Vaccines
- Subunit Subunit Vaccines
- Inactivated Vaccines
- Recombinant Vector Vaccines
- Toxoid Vaccines
- Synthetic Vaccines
- South Africa Vaccine Contract Manufacturing Market, by Service Type
- Fill-Finish
- Bulk Product
- South Africa Vaccine Contract Manufacturing Market, by Product Type
- Single Vaccine
- Combination Vaccine
- South Africa Vaccine Contract Manufacturing Market, by Vaccine Type
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Vaccine Contract Manufacturing Market, by Vaccine Type
- Live Attenuated Vaccines
- Conjugate Vaccines
- Subunit Subunit Vaccines
- Inactivated Vaccines
- Recombinant Vector Vaccines
- Toxoid Vaccines
- Synthetic Vaccines
- Rest of Middle East & Africa Vaccine Contract Manufacturing Market, by Service Type
- Fill-Finish
- Bulk Product
- Rest of Middle East & Africa Vaccine Contract Manufacturing Market, by Product Type
- Single Vaccine
- Combination Vaccine
- Rest of Middle East & Africa Vaccine Contract Manufacturing Market, by Vaccine Type
-
Middle East & Africa Vaccine Contract Manufacturing Market, by Vaccine Type
- North America
Vantage Market
Research | 07-Sep-2023
FAQ
Frequently Asked Question
What is the global demand for Vaccine Contract Manufacturing in terms of revenue?
-
The global Vaccine Contract Manufacturing valued at USD 3.1 Billion in 2022 and is expected to reach USD 7.4 Billion in 2030 growing at a CAGR of 11.5%.
Which are the prominent players in the market?
-
The prominent players in the market are Ajinomoto Co. Inc. (Japan), Albany Molecular Research Inc. (U.S.), Catalent Inc. (U.S.), Cobra Biologics Limited (UK), Cytovance Biologics Inc. (U.S.), Fujifilm Holdings Corporation (Japan), ICON PLC (Ireland), IDT Biologika GmbH (Germany), Lonza Group AG (Switzerland), Merck KGaA (Germany), Pharmaceutical Product Development LLC (U.S.), PRA Health Sciences Inc. (U.S.).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 11.5% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Vaccine Contract Manufacturing include
- Advancements in Technology and Cost Benefits in Infrastructure and Operational Benefits
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Vaccine Contract Manufacturing in 2022.
